+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Thrombin Market by Product Type (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), Application (Dental Surgery, Surgical Hemostasis, Trauma Care), End User, Formulation, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082821
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The thrombin market is evolving rapidly as healthcare providers and industry stakeholders seek advanced solutions to meet changing clinical, regulatory, and supply chain requirements. Strategic innovation, improved safety profiles, and agility in navigating regional trends have become key differentiators for leaders in this dynamic space.

Market Snapshot: Thrombin Market Growth and Trends

The thrombin market grew from USD 685.05 million in 2024 to USD 728.68 million in 2025. It is expected to continue growing at a CAGR of 6.25%, reaching USD 985.92 million by 2030. This expansion is driven by increasing demand for advanced hemostatic agents in surgical and trauma care, the adoption of recombinant thrombin technologies, and ongoing innovation in product formulations and delivery systems. Strategic responses to shifting global regulations and the emergence of new clinical guidelines are further shaping the competitive landscape and unlocking new opportunities for established and emerging market players alike.

Scope & Segmentation of the Thrombin Market

  • Product Types: Includes bovine thrombin, human thrombin, and recombinant thrombin, each supporting specific clinical applications and safety profiles.
  • Applications: Encompasses use in dental surgery, surgical hemostasis (including cardiac, general, neurosurgery, orthopedic surgeries), and trauma care scenarios.
  • End Users: Segment includes ambulatory surgery centers, clinics, and hospitals, all with differing priorities in terms of rapid turnaround, cost management, and integration into multidisciplinary care pathways.
  • Formulations: Covers gel, liquid forms, and lyophilized powder, each tailored for distinct surgical or storage requirements.
  • Distribution Channels: Features direct sales, distributors, hospital pharmacies, and online sales, providing broad geographic and customer access.
  • Regions Covered: Major focus on Americas, EMEA (Europe, Middle East & Africa), and Asia-Pacific, reflecting regional demands and varied adoption rates.
  • Key Companies Analyzed: Baxter International Inc., Johnson & Johnson, Pfizer Inc., Takeda Pharmaceutical Company Limited, Grifols S.A., CSL Limited, Haemonetics Corporation, Ferring B.V., Becton, Dickinson and Company, and Merck KGaA.
  • Technologies and Innovations: Incorporates advances in recombinant DNA technology, nanotechnology-based delivery systems, and the development of fully synthetic and hybrid hemostatic agents.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Recombinant thrombin formulations have reduced immunogenic risks while supporting consistent production quality, which is facilitating transition away from animal-derived products.
  • Recent innovations in thrombin gels, liquids, and hybrid matrices support minimally invasive surgeries and trauma care, in line with new clinical recovery protocols.
  • Regional market trends are shaped by local regulatory requirements, reimbursement models, and surgical infrastructure development—necessitating tailored strategies for entry and growth.
  • Point-of-care devices integrating thrombin activity with digital monitoring are emerging, enabling real-time intraoperative feedback for enhanced clinical outcomes.
  • Strategic partnerships, co-development agreements, and acquisitions are enabling companies to expand portfolios, integrate complementary technologies, and streamline distribution, driving stronger market competitiveness.

Tariff Impact: Navigating New Cost Structures and Supply Chain Dynamics

Amended US tariff schedules in 2025 have put upward pressure on thrombin manufacturing costs and disrupted traditional supply channels. Companies are shifting toward nearshoring or joint ventures with local suppliers, requiring capital investment but offering insulation against future trade volatility. In parallel, intensified payer negotiations and digital supply chain platforms are being leveraged to optimize pricing and procurement under new cost realities. These adaptations underscore the ongoing need for robust risk management and strategic supply chain planning.

Methodology & Data Sources

This market analysis is grounded in a robust mixed-methods approach, integrating primary interviews with clinical, procurement, and industry leaders, alongside quantitative surveys of manufacturing and distribution executives. Extensive secondary research includes regulatory documentation, clinical trial data, and trade information. Data triangulation ensures consistency and expert workshops validate findings, enabling high-confidence conclusions for critical business decisions.

Thrombin Market: Why This Report Matters

  • Enables senior decision-makers to benchmark current strategies against peer best practices in innovation, supply chain, and regional market entry.
  • Provides actionable insights for optimizing product portfolios, anticipating clinical trends, and maintaining compliance in evolving regulatory environments.
  • Supports informed investment, partnership, and sourcing decisions in a landscape characterized by technological advancement and increased competition.

Conclusion

The thrombin market is defined by rapid innovation, regulatory evolution, and dynamic competitive shifts. Organizations equipped with actionable market intelligence and agile strategies will strengthen their leadership and deliver superior clinical and operational value.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for recombinant thrombin in minimally invasive surgical procedures as hospitals seek efficient hemostasis solutions
5.2. Cost pressures driving adoption of thrombin biosimilars in emerging markets to enhance affordability and accessibility
5.3. Innovations in thrombin delivery systems such as nanoparticle formulations improving localized clotting control in trauma care
5.4. Strategic collaborations between biotech firms and medical device manufacturers to develop advanced thrombin-based hemostatic products
5.5. Regulatory harmonization and updated guidelines impacting thrombin product approvals across key regions including FDA and EMA
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Thrombin Market, by Product Type
8.1. Introduction
8.2. Bovine Thrombin
8.3. Human Thrombin
8.4. Recombinant Thrombin
9. Thrombin Market, by Application
9.1. Introduction
9.2. Dental Surgery
9.3. Surgical Hemostasis
9.3.1. Cardiac Surgery
9.3.2. General Surgery
9.3.3. Neurosurgery
9.3.4. Orthopedic Surgery
9.4. Trauma Care
10. Thrombin Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Clinics
10.4. Hospitals
11. Thrombin Market, by Formulation
11.1. Introduction
11.2. Gel
11.3. Liquid Form
11.4. Lyophilized Powder
12. Thrombin Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Hospital Pharmacies
12.5. Online Sales
13. Americas Thrombin Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Thrombin Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Thrombin Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Baxter International Inc.
16.3.2. Johnson & Johnson
16.3.3. Pfizer Inc.
16.3.4. Takeda Pharmaceutical Company Limited
16.3.5. Grifols, S.A.
16.3.6. CSL Limited
16.3.7. Haemonetics Corporation
16.3.8. Ferring B.V.
16.3.9. Becton, Dickinson and Company
16.3.10. Merck KGaA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. THROMBIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL THROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THROMBIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THROMBIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THROMBIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THROMBIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THROMBIN MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THROMBIN MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. THROMBIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. THROMBIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. THROMBIN MARKET: RESEARCHAI
FIGURE 26. THROMBIN MARKET: RESEARCHSTATISTICS
FIGURE 27. THROMBIN MARKET: RESEARCHCONTACTS
FIGURE 28. THROMBIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. THROMBIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THROMBIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THROMBIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THROMBIN MARKET SIZE, BY HUMAN THROMBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THROMBIN MARKET SIZE, BY HUMAN THROMBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THROMBIN MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THROMBIN MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THROMBIN MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THROMBIN MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THROMBIN MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THROMBIN MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THROMBIN MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THROMBIN MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THROMBIN MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THROMBIN MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THROMBIN MARKET SIZE, BY TRAUMA CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THROMBIN MARKET SIZE, BY TRAUMA CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THROMBIN MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THROMBIN MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THROMBIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THROMBIN MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THROMBIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THROMBIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THROMBIN MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THROMBIN MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THROMBIN MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THROMBIN MARKET SIZE, BY LIQUID FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL THROMBIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL THROMBIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL THROMBIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL THROMBIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL THROMBIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL THROMBIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL THROMBIN MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL THROMBIN MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 94. CANADA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 95. CANADA THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. CANADA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. MEXICO THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 106. MEXICO THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 107. MEXICO THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. GERMANY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. GERMANY THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. GERMANY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 168. GERMANY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 169. GERMANY THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. GERMANY THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. GERMANY THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. GERMANY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. FRANCE THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. FRANCE THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. FRANCE THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 180. FRANCE THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 181. FRANCE THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. FRANCE THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. FRANCE THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. FRANCE THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. FRANCE THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. FRANCE THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ITALY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. ITALY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ITALY THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. ITALY THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. ITALY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 204. ITALY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 205. ITALY THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ITALY THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ITALY THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. ITALY THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. ITALY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ITALY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SPAIN THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. SPAIN THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. SPAIN THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 216. SPAIN THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 217. SPAIN THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SPAIN THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. SPAIN THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. SPAIN THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. SPAIN THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. SPAIN THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. DENMARK THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. DENMARK THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. DENMARK THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 264. DENMARK THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 265. DENMARK THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. DENMARK THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 268. DENMARK THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 269. DENMARK THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. DENMARK THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. QATAR THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. QATAR THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. QATAR THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. QATAR THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. QATAR THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 288. QATAR THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 289. QATAR THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. QATAR THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. QATAR THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. QATAR THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. QATAR THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. QATAR THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. FINLAND THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. FINLAND THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. FINLAND THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 300. FINLAND THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 301. FINLAND THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. FINLAND THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FINLAND THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 304. FINLAND THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 305. FINLAND THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. FINLAND THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. EGYPT THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. EGYPT THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. EGYPT THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. EGYPT THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. EGYPT THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 336. EGYPT THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 337. EGYPT THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. EGYPT THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. EGYPT THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 340. EGYPT THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 341. EGYPT THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. EGYPT THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. TURKEY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 344. TURKEY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 345. TURKEY THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 346. TURKEY THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 347. TURKEY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 348. TURKEY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 349. TURKEY THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. TURKEY THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. TURKEY THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 352. TURKEY THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 353. TURKEY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. TURKEY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. ISRAEL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 356. ISRAEL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 357. ISRAEL THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 358. ISRAEL THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 359. ISRAEL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 360. ISRAEL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 361. ISRAEL THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 362. ISRAEL THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 363. ISRAEL THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 364. ISRAEL THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 365. ISRAEL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. ISRAEL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. NORWAY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 368. NORWAY THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 369. NORWAY THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 370. NORWAY THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 371. NORWAY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 372. NORWAY THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 373. NORWAY THROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 374. NORWAY THROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 375. NORWAY THROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 376. NORWAY THROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 377. NORWAY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 378. NORWAY THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 379. POLAND THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 380. POLAND THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 381. POLAND THROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 382. POLAND THROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 383. POLAND THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 384. POLAND THROMBIN MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Thrombin market report include:
  • Baxter International Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • CSL Limited
  • Haemonetics Corporation
  • Ferring B.V.
  • Becton, Dickinson and Company
  • Merck KGaA

Table Information